In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Yuag Meng Liu, Yao Shen Chen, Han Siong Toh, Chi Chang Huang, Yu Lin Lee, Cheng Mao Ho, Po Liang Lu, Wen Chien Ko, Yen Hsu Chen, Jen Hsien Wang, Hung Jen Tang, Kwok Woon Yu, Yung Ching Liu, Yin Ching Chuang, Yingchun Xu, Yuxing Ni, Chun Eng Liu, Po Ren Hsueh

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Abstract

The Study for Monitoring Antimicrobial Resistance Trends (SMART) is an international surveillance study designed to monitor resistance trends among aerobic and facultative Gram-negative bacilli (GNB) isolated from intra-abdominal infections. During 2003-2010, a total of 20710 GNB isolates were collected at medical centers in China, Hong Kong, Korea, New Zealand, and Taiwan. The susceptibility profiles of 2252 isolates of non-Enterobacteriaceae GNB were determined. At least 10 isolates of a given organism were required for that organism to be included in the analysis. Pseudomonas aeruginosa was the leading organism (49.2 of non-Enterobacteriaceae GNB), followed by Acinetobacter baumannii (21.5), Aeromonas spp. (11.6), and Stenotrophomonas maltophilia (9.1). All the other species/genera made up less than 2. The rates of susceptibility of the four major organisms were examined for two different time periods and according to whether the isolates had been obtained <48 h after hospitalization or ≥48 h after hospital admission. P. aeruginosa, Aeromonas spp., and S. maltophilia showed sustained levels of susceptibility to several antimicrobial agents in the two time periods, whereas A. baumannii exhibited very high rates of resistance to most antimicrobial agents including imipenem. Nosocomial P. aeruginosa and A. baumannii were more resistant than community-acquired pathogens, although this was not the case for Aeromonas spp. and S. maltophilia. Worldwide and regional surveillance is necessary to guide empirical antimicrobial therapy for infections due to non-Enterobacteriaceae GNB.

Original languageEnglish
Pages (from-to)S11-S17
JournalInternational journal of antimicrobial agents
Volume40
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2012 Jun

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)'. Together they form a unique fingerprint.

Cite this